In a significant leap forward for medtech innovation, ARS Pharmaceuticals has secured FDA approval for Neffy 1 mg, the first needle-free epinephrine nasal spray designed
Concord Biotech Plummets: Shares crashed 27% by Feb 14, capping a brutal week after a failed trial sank hopes—smallcap biotech’s reeling. Economic Times calls it
Latent Labs Unveils AI: On Feb 13, Latent Labs launched an AI platform targeting proteins and RNA for drug discovery, boasting 30% faster hit rates.
Pharma Bribery Risk Looms: Trump’s Feb 12 executive order paused enforcement of the Foreign Corrupt Practices Act, stirring fears of a bribery surge in global
Key Takeaways: Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS remain critical unmet needs in medicine. Biotech innovations, from gene therapies to biomarkers, are paving the
Key Takeaways: Wearable devices are advancing from fitness tracking to clinical-grade health monitoring. Innovations include devices for chronic disease management, remote patient monitoring, and mental
Key Takeaways: FDA approvals in 2025 have highlighted therapies addressing rare diseases, oncology, and chronic conditions. Innovative drugs with new mechanisms of action are transforming
Key Takeaways: AI is reshaping drug discovery, reducing timelines and costs through powerful data-driven algorithms. Tools like machine learning and predictive modeling are identifying targets
Key Takeaways: CRISPR revolutionized genome editing, but new technologies are pushing the boundaries even further. Base editing, prime editing, and epigenome editing offer improved precision
Overview: A look at the major biotech, medtech, and pharma conferences in 2025. Key Details: Dates, locations, and highlights from each event. Industry Impact: Why
